EP1137659A4 - Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof - Google Patents

Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof

Info

Publication number
EP1137659A4
EP1137659A4 EP99962723A EP99962723A EP1137659A4 EP 1137659 A4 EP1137659 A4 EP 1137659A4 EP 99962723 A EP99962723 A EP 99962723A EP 99962723 A EP99962723 A EP 99962723A EP 1137659 A4 EP1137659 A4 EP 1137659A4
Authority
EP
European Patent Office
Prior art keywords
angiogenesis
inhibition
molecular weight
high molecular
peptide analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99962723A
Other languages
German (de)
French (fr)
Other versions
EP1137659A1 (en
Inventor
R Keith Mccrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Publication of EP1137659A1 publication Critical patent/EP1137659A1/en
Publication of EP1137659A4 publication Critical patent/EP1137659A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP99962723A 1998-11-10 1999-11-05 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof Withdrawn EP1137659A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10783398P 1998-11-10 1998-11-10
US107833P 1998-11-10
PCT/US1999/026419 WO2000027866A1 (en) 1998-11-10 1999-11-05 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof

Publications (2)

Publication Number Publication Date
EP1137659A1 EP1137659A1 (en) 2001-10-04
EP1137659A4 true EP1137659A4 (en) 2005-08-10

Family

ID=22318715

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99962723A Withdrawn EP1137659A4 (en) 1998-11-10 1999-11-05 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof

Country Status (8)

Country Link
EP (1) EP1137659A4 (en)
JP (1) JP2002529474A (en)
AU (1) AU773862B2 (en)
CA (1) CA2350915A1 (en)
IL (1) IL142822A0 (en)
NZ (1) NZ511618A (en)
WO (1) WO2000027866A1 (en)
ZA (1) ZA200104130B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034195A1 (en) * 1999-11-12 2001-05-17 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
AU2001277119A1 (en) * 2000-07-24 2002-02-25 Attenuon, Llc Human kininogen d5 domain polypeptides and their use
US7098187B2 (en) 2002-09-13 2006-08-29 Attenuon, Llc Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
SE0301431D0 (en) 2003-05-19 2003-05-19 Dermagen Novel antimicrobial peptides
GB0821721D0 (en) * 2008-11-27 2008-12-31 Hansa Medical Ab Antimicrobial therapy
CN104211807B (en) * 2014-08-22 2017-10-20 北京蛋白质组研究中心 It is a kind of to resist monoclonal antibody of two kinds of polypeptides and its preparation method and application
CN104155457B (en) * 2014-08-22 2016-11-16 北京蛋白质组研究中心 Relevant " the box-like mark of the polypeptide-protein groups " detection kit of a kind of colorectal cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596079A (en) * 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
US5756291A (en) * 1992-08-21 1998-05-26 Gilead Sciences, Inc. Aptamers specific for biomolecules and methods of making
JPH0782172A (en) * 1993-09-17 1995-03-28 Hoechst Japan Ltd Wound healing agent
US5981483A (en) * 1994-05-04 1999-11-09 Mount Sinai Hospital Corporation Compositions comprising modulators of cytokines of the TGF-β superfamily
JPH08208692A (en) * 1994-09-28 1996-08-13 Sumitomo Pharmaceut Co Ltd New cell adhesion inhibiting peptide derivative
EP0808627A2 (en) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof
CA2187728A1 (en) * 1996-05-29 1997-11-29 Mary Lou Guerinot Iron-regulated metal transporters and uses therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
AU773862B2 (en) 2004-06-10
JP2002529474A (en) 2002-09-10
AU1910600A (en) 2000-05-29
IL142822A0 (en) 2002-03-10
CA2350915A1 (en) 2000-05-18
WO2000027866A1 (en) 2000-05-18
ZA200104130B (en) 2002-05-21
EP1137659A1 (en) 2001-10-04
NZ511618A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
DE69929887D1 (en) Hepatitis c inhibitor peptide
EP1115738A4 (en) Synthesis of cyclic peptides
PL334305A1 (en) Cycloalkylic, lactamic, lactonic and affinite compounds, pharmaceutic agents containing them and methods of inhibiting beta-amyloid peptide release and/or synthesis thereof employing such compounds
EP1140144A4 (en) Composition of highly purified natural mixtures of type i interferon derived from leukocytes and methods
EP0831920A4 (en) Novel cathepsin and methods and compositions for inhibition thereof
IL142822A0 (en) Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
ZA9711055B (en) Pharmaceutical compositions for freeze drying
IL143651A0 (en) Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
PL337616A1 (en) Cyclic azapeptides of angiogenic properties
AU9484398A (en) Promotion or inhibition of angiogenesis and cardiovascularization
EP1044012A4 (en) Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
HUP0000588A3 (en) Preparation of purified (poly)peptides
IL141537A0 (en) Promotion or inhibition of angiogenesis and cardiovascularization
HUP0000490A3 (en) Cyclic peptide derivatives
GB9214830D0 (en) Peptide compositions
EP1227842A4 (en) Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
IL122343A0 (en) Inhibition of nuclear import by backbone cyclic peptide analogs
EP1048223A4 (en) Sweetener compositions containing aspartame and aspartame derivative
GB9720369D0 (en) New sweetening compositions of aspartame
TW323453U (en) Improved structure of necktie
DE69633463D1 (en) ICE INHIBITING PEPTIDES
GB9615314D0 (en) Inhibition of respiratory infection
EP1230928A4 (en) Use of peptide
IL133427A0 (en) Peptides derived from complement peptide c3a sequence and antiallergic compositions comprising them
TW364347U (en) Structure of necktie set assembly

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 07K 7/08 B

Ipc: 7A 61K 38/36 B

Ipc: 7A 61K 38/08 B

Ipc: 7A 61K 38/07 B

Ipc: 7C 07K 5/10 B

Ipc: 7C 07K 14/745 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 7/00 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61K 31/47 B

Ipc: 7C 07H 21/04 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050622

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050913